Transgender Health clinical trials at University of California Health
6 in progress, 2 open to eligible people
Androgen Effects on the Reproductive Neuroendocrine Axis
open to eligible females ages 18-35
This research study investigates whether male-level exogenous androgens inhibit the reproductive neuroendocrine axis in otherwise healthy (non-PCOS) females.
at UCSD
Digital Limited Interaction Efficacy Trial of LifeSkills Mobile to Reduce HIV Incidence in YTW
open to eligible males ages 16-29
The LifeSkills Mobile app will be evaluated in a randomized controlled trial (RCT) among 5,000 young transgender women (YTW), ages 16-29 in the United States (U.S.). Study findings will demonstrate if the intervention will reduce HIV incidence.
at UCLA
Emtricitabine/Tenofovir Alafenamide Switch Study for Transgender Individuals for HIV Pre-exposure Prophylaxis
Sorry, in progress, not accepting new patients
The purpose of this study is to evaluate Pre-Exposure Prophylaxis (PrEP) levels in transgender-identifying or gender non-binary individuals taking versus not taking gender affirming hormone therapy. Subjects who have previously taken F/TDF as PrEP…
at UCSD
Estradiol Therapy In Transgender Women to Research Interactions With HIV Therapy
Sorry, in progress, not accepting new patients
Transgender women (TW) are a key population and priority for HIV treatment. More research is needed to develop evidence-based clinical guidance when it comes to choosing antiretroviral treatment (ART) regimens for TW on feminizing hormonal therapy…
at UCSD UCSF
Lenacapavir for HIV Pre-Exposure Prophylaxis in People Who Are at Risk for HIV Infection
“Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!”
Sorry, in progress, not accepting new patients
The goal of this clinical study is to test how well the study drug, lenacapavir (LEN), works in preventing the risk of HIV.
at UCLA UCSD
Support for Transgender and Non-Binary Individuals Seeking Vaginoplasty Study
Sorry, accepting new patients by invitation only
The STRIVE study is the first national randomized trial to focus on improving well-being, access to surgical care and other health outcomes for transgender and nonbinary (referred to as trans) people seeking genital gender-affirming surgery (GGAS).…
at UCSF
Our lead scientists for Transgender Health research studies include Matthew J Mimiaga, ScD, MD Sheldon Morris, MD Jesse L. Clark, MD Antoni Duleba, MD.
Last updated: